The FDA today issued a public health advisory about reports of a rare brain infection in people using the psoriasis drug Raptiva.
According to the FDA, there have been three confirmed and one possible case of progressive multifocal leukoencephalopathy (PML) in people taking Raptiva; three of those people died.
Psoriasis Drug Raptiva Tied to Brain Infection
The U.S. government has given an ultimatum to the international group that helps provide vaccines to...
